Affimed N.V.

Affimed N.V.verified

AFMD

Price:

$5.55

Market Cap:

$77.46M

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase IIa clinical trial for the treatment of advanced cancers; AFM28, an innate cell engager (ICE), which is in preclinical development to treat acute myeloid ...[Read more]

Industry

Biotechnology

IPO Date

2014-09-12

Stock Exchange

NASDAQ

Ticker

AFMD

The PE Ratio as of July 2024 (TTM) for Affimed N.V. (AFMD) is -0.82

According to Affimed N.V.’s latest financial reports and current stock price. The company's current PE Ratio is -0.82. This represents a change of -8.88% compared to the average of -0.90 of the last 4 quarters.

Affimed N.V. (AFMD) Historical PE Ratio (quarterly & annually)

How has AFMD PE Ratio performed in the past?

The mean historical PE Ratio of Affimed N.V. over the last ten years is -56.06. The current -0.82 PE Ratio has changed 46.26% with respect to the historical average. Over the past ten years (40 quarters), AFMD's PE Ratio was at its highest in in the March 2021 quarter at 138.72. The PE Ratio was at its lowest in in the March 2015 quarter at -24.43.

Quarterly (TTM)
Annual

Average

-56.06

Median

-6.64

Minimum

-512.31

Maximum

-0.80

Affimed N.V. (AFMD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Affimed N.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 13.35%

Maximum Annual PE Ratio = -0.80

Minimum Annual Increase = -98.20%

Minimum Annual PE Ratio = -512.31

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.80-58.40%
2022-1.92-80.99%
2021-10.084.95%
2020-9.6198.14%
2019-4.85-42.44%
2018-8.43408.23%
2017-1.66-5.92%
2016-1.76-80.90%
2015-9.22-98.20%
2014-512.3113.35%

Affimed N.V. (AFMD) Average PE Ratio

How has AFMD PE Ratio performed in the past?

The current PE Ratio of Affimed N.V. (AFMD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-4.27

5-year avg

-5.45

10-year avg

-56.06

Affimed N.V. (AFMD) PE Ratio vs. Peers

How is AFMD’s PE Ratio compared to its peers?

Affimed N.V.’s PE Ratio is less than TCR2 Therapeutics Inc. (-0.44), less than Pieris Pharmaceuticals, Inc. (-0.59), greater than ADC Therapeutics SA (-1.39), less than Agenus Inc. (-0.65), greater than X4 Pharmaceuticals, Inc. (-1.14), greater than Terns Pharmaceuticals, Inc. (-7.16), greater than Day One Biopharmaceuticals, Inc. (-6.46), greater than PDS Biotechnology Corporation (-3.15), greater than Inozyme Pharma, Inc. (-4.47), greater than Leap Therapeutics, Inc. (-1.09), greater than Adaptimmune Therapeutics plc (-1.79), greater than Corvus Pharmaceuticals, Inc. (-4.44), less than Aptose Biosciences Inc. (-0.18), less than eFFECTOR Therapeutics, Inc. (-0.01), greater than Elevation Oncology, Inc. (-3.31), greater than Mereo BioPharma Group plc (-78.07), less than Hepion Pharmaceuticals, Inc. (-0.14),

Build a custom stock screener for Affimed N.V. (AFMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Affimed N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Affimed N.V. (AFMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Affimed N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Affimed N.V.'s PE Ratio?

How is the PE Ratio calculated for Affimed N.V. (AFMD)?

What is the highest PE Ratio for Affimed N.V. (AFMD)?

What is the 3-year average PE Ratio for Affimed N.V. (AFMD)?

What is the 5-year average PE Ratio for Affimed N.V. (AFMD)?

How does the current PE Ratio for Affimed N.V. (AFMD) compare to its historical average?